North East and North Cumbria Formulary


	North East and North Cumbria ICS Formulary

Search

Results

Looking for Amivantamab found 5 matches

Open monograph to display formulary status		BNF Category
	Amivantamab (Rybrevant^®)	Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
	Lazertinib	Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05

Links

Link to Drug Section

Link to document

NICE TA1122: Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer (08.01.05)

NICE TA1122: Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer (08.01.05)

NICE TA1158: Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer (08.01.05)